Changjiang Securities Co., Ltd. (hereinafter referred to as "Changjiang Securities" or "the Sponsor") acted as the sponsor for Yili Chuaning Biotechnology Co., Ltd. (hereinafter referred to as "Chuaning Biotechnology" or "the Company") during its initial public offering (IPO). In accordance with the "Shenzhen Stock Exchange GEM Listing Rules," "Self-Regulatory Guidelines No. 2 for Listed Companies on the Shenzhen Stock Exchange," "Regulations on the Supervision of Fundraising by Listed Companies," and "Self-Regulatory Guidelines No. 13 for Sponsorship Business," as well as other relevant laws, regulations, and normative documents, the Company’s fundraising storage and actual usage for 2025 were verified. The specific situation is as follows:
1. Basic Situation of Fundraising
(1) Actual Amount Raised and Receipt Time
On October 26, 2022, the China Securities Regulatory Commission issued the "Approval for Yili Chuaning Biotechnology Co., Ltd.'s Initial Public Offering Registration" (Zheng Jian Xu Ke [2022] No. 2574), approving the Company to publicly issue 222,800,000 shares of ordinary shares (A shares) with a par value of RMB 1.00 per share at an issue price of RMB 5.00 per share, raising a total of RMB 1,114,000,000.00. After deducting underwriting fees, legal fees, audit fees, information disclosure fees, issuance procedure fees, and other expenses totaling RMB 92,316,909.17, the net amount raised by the Company was RMB 1,021,683,090.83, of which the total amount of oversubscription funds was RMB 421,683,090.83. The funds were received on December 22, 2022, and Tianjian Certified Public Accountants (Special General Partnership) verified the funds' arrival, issuing Verification Report No. Tianjian Yan [2022] No. 8-48.
(2) Usage and Balance of Fundraising
As of December 31, 2025, the Company’s usage of the raised funds is as follows:
| Project | Amount (10,000 RMB) |
|---|---|
| Total Amount Raised | 111,400.00 |
| Net Amount Raised | 102,168.31 |
| Total Amount Invested in Reporting Period | 5,598.38 |
| Total Amount Invested Cumulatively | 96,620.86 |
| Net Interest Income Deducted from Fees | 828.05 |
| Payable Issuance Fees Not Paid with Raised Funds | 57.76 |
| Balance of Special Fund Account as of December 31, 2025 | 6,433.26 |
2. Storage and Management of Fundraising
(1) Management of Fundraising
To standardize the management and use of the raised funds and protect investors' interests, the Company has implemented a special account storage system for the raised funds in accordance with the "Regulations on the Supervision of Fundraising by Listed Companies" and "Self-Regulatory Guidelines No. 2 for Listed Companies on the Shenzhen Stock Exchange." The Company opened special accounts for the raised funds at Bank of China Yili Branch, Agricultural Bank of China Yili Branch, Industrial and Commercial Bank of China Yining Cooperative Zone Branch, Industrial Bank Yili Branch, and Industrial and Commercial Bank of China Gongliu Branch. The Company and its subsidiaries signed tripartite and quadripartite supervision agreements with the sponsor (lead underwriter) and the banks holding the special accounts to supervise the storage and usage of the raised funds. The agreements do not differ significantly from the Shenzhen Stock Exchange's tripartite supervision agreement template, and the Company strictly adheres to these agreements when using the raised funds to ensure dedicated use and truthful disclosure.